-
Ann. Clin. Biochem. · May 2012
Case ReportsTwo novel mutations in the L ferritin coding sequence associated with benign hyperferritinaemia unmasked by glycosylated ferritin assay.
- Vanessa Thurlow, Bipin Vadher, Adrian Bomford, Corinne DeLord, Caroline Kannengiesser, Carole Beaumont, and Bernard Grandchamp.
- Department of Pathology, Princess Royal University Hospital, Farnborough, Orpington, Kent BR6 8ND, UK. vanessa.thurlow@gmail.com
- Ann. Clin. Biochem. 2012 May 1; 49 (Pt 3): 302-5.
AbstractInvestigating persistent hyperferritinaemia without apparent iron overload is challenging. Even when inflammation, cirrhosis, Still's disease, fatty liver and malignancy are excluded, there remains a group of patients with unexplained hyperferritinaemia for whom rare forms of haemochromatosis (ferroportin disease) are a consideration. Preliminary results suggest that abnormal percentage glycosylation of serum ferritin is seen in some cases of genetically determined hyperferritinaemia. Serum ferritin is normally 50-81% glycosylated, but low glycosylation (20-42%) prevails in hereditary hyperferritinaemia cataract syndrome. This contrasts with hyperglycosylation (>90%) associated with the benign hyperferritinaemia related to missense L ferritin (p.Thr30Ile) mutation. Here, we describe two novel missense L ferritin variants also associated with hyperglycosylation, p.Gln26Ile and p.Ala27Val. Ferritin glycosylation, a comparatively simple measurement, can identify patients for DNA sequencing as hyperglycosylation (>90%) is associated with benign hyperferritinaemia and mutant L ferritin chain.
Notes
Knowledge, pearl, summary or comment to share?